Search Results - "Basset, N"

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial by Basset-Séguin, N., Hauschild, A., Kunstfeld, R., Grob, J., Dréno, B., Mortier, L., Ascierto, P.A., Licitra, L., Dutriaux, C., Thomas, L., Meyer, N., Guillot, B., Dummer, R., Arenberger, P., Fife, K., Raimundo, A., Dika, E., Dimier, N., Fittipaldo, A., Xynos, I., Hansson, J.

“…The SafeTy Events in VIsmodEgib study (STEVIE, ClinicalTrials.gov, NCT01367665), assessed safety and efficacy of vismodegib—a first-in-class Hedgehog pathway…”
Get full text

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion by Dummer, R., Ascierto, P.A., Basset‐Seguin, N., Dréno, B., Garbe, C., Gutzmer, R., Hauschild, A., Krattinger, R., Lear, J.T., Malvehy, J., Schadendorf, D., Grob, J.J.

“…Sonidegib and vismodegib are hedgehog pathway inhibitors (HhIs) approved for the treatment of advanced basal cell carcinoma (BCC). Until recently, vismodegib…”
Get full text

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses by Morton, C.A., Szeimies, R.‐M., Basset‐Séguin, N., Calzavara‐Pinton, P.G., Gilaberte, Y., Hædersdal, M., Hofbauer, G.F.L., Hunger, R.E., Karrer, S., Piaserico, S., Ulrich, C., Wennberg, A.‐M., Braathen, L.R.

“…In addition to approved indications in non‐melanoma skin cancer in immunocompetent patients, topical photodynamic therapy (PDT) has also been studied for its…”
Get full text

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas by Morton, C.A., Szeimies, R.‐M., Basset‐Seguin, N., Calzavara‐Pinton, P., Gilaberte, Y., Hædersdal, M., Hofbauer, G.F.L., Hunger, R.E., Karrer, S., Piaserico, S., Ulrich, C., Wennberg, A.‐M., Braathen, L.R.

“…Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, Bowen's disease (squamous cell carcinoma in situ), superficial and…”
Get full text

Integrating the selection of PHA storing biomass and nitrogen removal via nitrite in the main wastewater treatment line by Basset, N., Katsou, E., Frison, N., Malamis, S., Dosta, J., Fatone, F.

“…[Display omitted] •Selection of PHA storing biomass was integrated with N removal in municipal WWTP.•N removal via nitrite was achieved using fermented…”
Get full text

Two-step partial nitritation/Anammox process in granulation reactors: Start-up operation and microbial characterization by Dosta, J., Vila, J., Sancho, I., Basset, N., Grifoll, M., Mata-Álvarez, J.

“…A two-stage Partial Nitritation (PN)/Anammox process was carried out at lab-scale conditions to treat reject water from a municipal WWTP. PN was achieved in a…”
Get full text

Characterization of patients with advanced basal cell carcinoma progressing while receiving Hedgehog pathway inhibitors by Monnet, P., Herms, F., Djermane, M., Dalac, S., Dereure, O., Dréno, B., Beylot‐Barry, M., Mortier, L., Basset‐Seguin, N.

Get full text

Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy by Haddad, N., Delyon, J., Trabelsi Messai, S., Herms, F., Leccia, M.T., Lebbe, C., Whitney, J., Bhatia, S., Basset‐Seguin, N.

Get full text

Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas by Grob, J.J., Gaudy‐Marqueste, C., Guminski, A., Malvehy, J., Basset‐seguin, N., Bertrand, B., Fernandez‐Penas, P., Kaufmann, R., Zalaudek, I., Fargnoli, M.C., Tagliaferri, L., Fertil, B., Del Marmol, V., Stratigos, A., Garbe, C., Peris, K.

“…Background No simple staging system has emerged for basal cell carcinomas (BCCs), since they do not follow the TNM process, and practitioners failed to agree…”
Get full text

Usefulness of the ‘two‐step method’ of digital follow‐up for early‐stage melanoma detection in high‐risk French patients: a retrospective 4‐year study by Gasparini, G., Madjlessi, N., Delyon, J., Carmisciano, L., Brahimi, N., Basset‐Seguin, N., Oren, M., Battistella, M., Lebbé, C., Herms, F., Baroudjian, B.

Get full text

Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition by Grob, J.J., Guminski, A., Malvehy, J., Basset‐seguin, N., Bertrand, B., Fernandez‐Penas, P., Kaufmann, R., Zalaudek, I., Gaudy‐Marqueste, C., Fargnoli, M.C., Tagliaferri, L., Fertil, B., Del Marmol, V., Stratigos, A., Garbe, C., Peris, K.

“…Background No simple classification system has emerged for ‘advanced basal cell carcinomas’, and more generally for all difficult‐to‐treat BCCs (DTT‐BCCs), due…”
Get full text

Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology by Wiegell, S R, Wulf, H C, Szeimies, R-M, Basset-Seguin, N, Bissonnette, R, Gerritsen, M-J P, Gilaberte, Y, Calzavara-Pinton, P, Morton, C A, Sidoroff, A, Braathen, L R

“…Photodynamic therapy (PDT) is an attractive therapy for non-melanoma skin cancers including actinic keratoses (AKs) because it allows treatment of large areas;…”
Get full text

Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients by Chapalain, M., Baroudjian, B., Dupont, A., Lhote, R., Lambert, J., Bagot, M., Lebbe, C., Basset‐Seguin, N.

“…Background The prevalence and incidence of cutaneous squamous cell carcinoma (cSCC) are increasing due to the ageing of the population and sun exposure…”
Get full text

Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians by Dréno, B, Amici, J M, Basset-Seguin, N, Cribier, B, Claudel, J P, Richard, M A

“…Actinic keratoses (AK) are common photo-induced cutaneous lesions that may progress to invasive squamous-cell carcinoma and serve as a risk marker for skin…”
Get full text

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe by Lacour, J-P., Ulrich, C., Gilaberte, Y., Von Felbert, V., Basset-Seguin, N., Dreno, B., Girard, C., Redondo, P., Serra-Guillen, C., Synnerstad, I., Tarstedt, M., Tsianakas, A., Venema, A.W., Kelleners-Smeets, N., Adamski, H., Perez-Garcia, B., Gerritsen, M.J., Leclerc, S., Kerrouche, N., Szeimies, R-M.

“…Background Unmet needs exist in actinic keratosis (AK) treatment. Daylight photodynamic therapy (DL‐PDT) has shown good efficacy and safety results compared to…”
Get full text

Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus by Morton, C.A., Wulf, H.C., Szeimies, R.M., Gilaberte, Y., Basset-Seguin, N., Sotiriou, E., Piaserico, S., Hunger, R.E., Baharlou, S., Sidoroff, A., Braathen, L. R.

“…Introduction Daylight‐mediated photodynamic therapy has been shown to be an effective therapy for actinic keratoses (AKs) and a simple and tolerable treatment…”
Get full text

Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians by Richard, M. A., Amici, J. M., Basset‐Seguin, N., Claudel, J.P., Cribier, B., Dreno, B.

“…Actinic keratoses (AK) arise on sun‐exposed regions of the skin. If left untreated, AK may progress to invasive squamous cell carcinoma (SCC), although the…”
Get full text

Actinic cheilitis: a systematic review of treatment options by Trager, M.H., Farmer, K., Ulrich, C., Basset‐Seguin, N., Herms, F., Geskin, L.J., Bouaziz, J.‐D., Lebbé, C., Masson, A., Bagot, M., Dobos, G.

“…Actinic cheilitis is a premalignant condition that can progress to squamous cell carcinoma with a higher propensity for metastasis than cutaneous squamous cell…”
Get full text

Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study by Garbe, C., Basset-Seguin, N., Poulin, Y., Larsson, T., Østerdal, M.L., Venkata, R., Lear, J.T.

“…Summary Background Ingenol mebutate (IngMeb) is a novel patient‐applied topical field therapy for actinic keratosis. Objectives To demonstrate the efficacy and…”
Get full text

ORP slope and feast–famine strategy as the basis of the control of a granular sequencing batch reactor treating winery wastewater by López-Palau, S., Pinto, A., Basset, N., Dosta, J., Mata-Álvarez, J.

“…► Organic matter from winery wastewater was removed by aerobic granulation in a SBR. ► Frequent COD fluctuations of winery effluents were properly treated. ► A…”
Get full text